Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 11, 1998, Pages 1195-1199

  Morris, Jonathan M ^a   Gopaul, Nitin K ^b   Endresen, Marit J R ^a   Knight, Marian ^a   Linton, Elizabeth A ^a   Dhir, Suman ^b   Ängård, Eric E ^b   Redman, Christopher W G ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CRESOL; LIPID HYDROPEROXIDE; LIPID PEROXIDE; MALONALDEHYDE; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; AUTOOXIDATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; OXIDATIVE STRESS; PARITY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTAGLANDIN BLOOD LEVEL; UNITED KINGDOM; VITAMIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; DINOPROST; FEMALE; HUMANS; LIPID PEROXIDES; MALONDIALDEHYDE; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDIES; VITAMIN E;

EID: 0031729762     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb09974.x     Document Type: Article

References (35)

1. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991: 4: 700–708.
2. Chun S, Braga C, Chow C, Lok L. Clinical observations on some aspects of hydatidiform moles. J Obstet Gjnnerol Br Comndtlt 1964; 71: 180–184.
3. Genbacev O, Josh R. Damsky CH. Polliotti BM, Fisher SJ. Hypoxia alters early gestation human cytotrophoblast differentia tionlinvasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996; 97: 540–550.
4. Morris JM, Fay RA. Ellwood DA, Cook CM. Devonald KJ. A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow. Obstet Gynecol 1996; 87: 7478.
5. McCord JM. Oxygen derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159–163.
6. Kaneko T, Nakano S, Matsuo M. Protective effect of vitamin E on linoleic acid hydroperoxide-induced injury to human endothelial cells. Lipids 1991; 26: 345–348.
7. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rodgers GM, McLaughlin MK. Lipid peroxidation in pregnancy: new perspectives on pre-eclampsia. Am J Ohstet Gjnwol 1989; 161: 1025–1034.
8. Sane AS, Chokshi SA, Mishra VV, Barad DP, Shah VC, Nagpal S. Serum lipoperoxide levels in pregnancy induced hypertension. Pan Medica 1989; 31: 119–122.
9. Maseki M, Nishigaki I, Hagihara M, Tomoda Y, Yagi K. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia. Clin Chim Acta 1981; 115: 151–161.
10. Pain SK, Wise R. Relationship between elevated lipid peroxides, vitamin E deficiency and hypertension in pre-eclampsia. Mol cell Biochem 1995; 151: 33–38.
11. Uotila JT, Tuimaia RJ, Aarnio TM. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Br J Obstet Gynuecol 1993; 100: 270–276.
12. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 1996; 174: 975–982.
13. Davidge ST, Hubel CA, Brayden RD, Capeless EC, McLaughlin MK. Sera antioxidant activity in uncomplicated and pre-eclamptic pregnancies. Ohstrt Gynecol 1992; 79 897–901.
14. Wickens D, Wilkins MH, Lunec J, Ball G, Dormandy TL. Free-radical oxidation (peroxidation) products in plasma in normal and abnormal pregnancy. Ann Clin Biochem 1981; 18:158–162.
15. Cargnoni A, Gregorini G, Ceconi C, Maiorca R, Ferrari R. Lipid peroxidation in normal pregnancy and preeclampsia. Adv Exp Med Biol 1994; 366:420–421.
16. Erskine KJ, Iversen SA, Davies R. An altered ratio of 18: 2 (9,11) to (9. 12) linoleic acid in plasma phosholipids as a possible predictor of pre-eclampsia. Luncet 1985; 1: 554–555.
17. Iioka H. Changes in blood level of lipid peroxide and vitamin E during pregnancy: clinical significance and relation to the pathogenesis of EPH gestosis. Gynecol Ohstet Invest 1994; 38: 173–176.
18. Morrow JD, Minton TA, Mukundan CR et al. Free radical induced generation of isoprostanes in vivo. J Biol Chem 1994; 269 4317–4326.
19. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non cyclooxygenase, free radical catalysed mechanism Proc Natl Acad Sci USA 1990; 87:9383–9387.
20. Takabashi K, Nammour TM, Fukunaga M et al. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Invest 1992; 90 136–141.
21. Morrow JD, Minton TA, Roberts LJ. The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxard endoperoxide receptor antagonist. Prostaglandins 1992; 44:155–163.
22. Fukunaga M, Yura T, Badr KF. Stimulatory effect of 8-Epi-PGF2 alpha, an F2-isoprostane, on endothelin-l release. J Cardiovasc Phurmacol 1995; 26 (Suppl 3): S51–S52.
23. Nourooz-Zadeh J, Gopaul NK, Barrow S, Mallet AI, Anggard E. Analysis of F2 Isprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas-chromatography-mass spectrometry: development of a solid phase extraction procedure. J Chmniutog 1995; 667 199–208.
24. Yagi K. Assay for serum lipid peroxide level and its clinical signify cance. In: Yagi K, editor. Lipid Peroxidese in Biology and Medicine. New York: Academic Press, 1982: 223–242.
25. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 1994; 220:403409.
26. Barden A, Beilen LJ, Ritchie J, Croft KD, Walters BN, Michael CA. Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin Sci 1996; 91:711–718.
27. Hendriks T, Assmann RE On the fluometric assay of circulating lipoperoxides. Clin Chim Acta 1988; 174 263–270.
28. Duthie GC, Morrice PC, Ventresca PG, McLay JS. Effects of storage, iron and time of day on indices of lipid peroxidation in plasma from healthy volunteers. Clin Chim Acta 1992; 206: 207–213.
29. Morrow JD, Harris TM, Roberts LJ. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical rami fications for measurement of eicosanoids. Anal Biochem 1990; 184: 1–10.
30. Wang Y, Walsh SW, Guo J, Zhang J. Maternal levels of prostacyclin, thromboxane, vitamin E and lipid peroxides throughout normal pregnancy. Am J Ohstet Gynecol 1991; 165: 1690–1694.
31. Sacks GP, Studena K, Sargent IL, Redman CWG. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leckocytes akin to those of sepsis. Am J Ohstet Gynecol. 1998; 179 80–86.
32. Wang YP, Walsh SW, Guo JD, Zhang JY. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 1991; 165:1695–1700.
33. Hubel CA. Plasma vitamin E in preeclamspia. Am J Ohstet Gynecol 1997; 177 484–485.
34. Toborek M, Barger SW, Mattson MP, Barve S, McClain CJ, Hennig B. Linoleic acid and TNF-a cross-amplify oxidative injury and dysfunction of endothelial cells. J Lip Res 1996; 37: 123–135.
35. Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MM. Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. Br J Obstet Gynaecol 1997; 104: 689–696.